欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/0487/001
药品名称Vesicare 5 mg
活性成分
    • Solifenacin succinate 5.0 mg
剂型Film-coated tablet
上市许可持有人Astellas Pharma Europe B.V. Sylviusweg 62 2333 BE Leiden The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Vesicare 5 mg
互认成员国 - 产品名称
    • Lithuania (LT)
      Vesicare 5 mg plėvele dengtos tabletės
    • Hungary (HU)
    • Cyprus (CY)
      vesicare 5MG fc tabs
    • Czechia (CZ)
    • Slovakia (SK)
      Vesicare 5 mg
    • Slovenia (SI)
    • Malta (MT)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Vesicare 5 mg - Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Liechtenstein (LI)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Vesicare 5 mg
许可日期2004/06/08
最近更新日期2024/10/07
药物ATC编码
    • G04BD08 solifenacin
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase